saxenda glp-1 diabetes market impact Oral to Rise at 35.05% CAGR till 2035 Market Overview: GLP-1 Agonists and

Any score greater than 8 kPA on VCTE should be referred to Hepatology for further assessment

Methods: In this study, participants with NAFLD aged 40 years or over from the Third National Health and Nutrition Examination Survey (NHANES III) and NHANES 19992010 were included

Clinicians are uniquely positioned to identify patient-specific needs and integrate GLP-1R agonists into personalized treatment plans, especially for those with T2DM, obesity, and related metabolic conditions

As long as you inject it correctly into your abdomen, thigh, or upper arm, the drug should have the same effect

Conclusion: Among patients with HTN, MASLD, and obesity, statin users were significantly associated with a lower incidence of CV disease and reduced risk of mortality, which further supports current guidelines recommending statin use in patients with liver disease and high-risk populations